Ca2+/calmodulin is involved in growth factor-induced retinoblastoma gene product phosphorylation in human vascular endothelial cells  by Takuwa, Noriko et al.
Volume 306, number 2,3, 173-175 FEBS 11293 
© 1992 Federation of European Biochemical Societies 00145793/9~$5.00 
July 1992 
Ca2+/calmodulin is involved in growth factor-induced retinoblastoma 
gene product phosphorylation in human vascular endothelial cells 
Noriko Takuwa, Wei Zhou, Mamoru  Kumada and Yoh Takuwa 
Departments ofPhysiology and Cardiovascular Biology, Faculty of Medicbte, University of Tokyo, Tokyo 113, Japan 
Received 22 May 1992 
In haman vascular endothelial cells, both growth factor-induced DNA synthesis and retinoblastoma gene product (RB) phosphorylation are 
absolutely dependent on e~tracellular Ca'+. and are potently inhibited by an active calmodulin antagonist, W-7, but not an inactive analogue, W-I 2. 
A reduction in the extracellular Ca :~ or an addition of W.7 as late as 8 h after growth factc, r stimulation still inhibits both RB phosphorylation 
and DNA synthesis to the full e~tent, However, once RB phosphor'clatlon ccurs 12-16 h after addition of the 8rowth factors, it is not reversed 
by subsequent Ca"" reduction or W-7. These results uggest the existence of a Ca-'+/calmodulin-dependent procc'ss relatively late in the mitogenic 
signalling cascade, at a step proximal to RB phosphorylatlon reaction itself. 
Retinoblastoma gene product (RB); RB protein; Ca-'*; Calmodulin; Endothelial cell 
1. INTRODUCTION 
It has been well documented that Ca "~÷ is indispensa- 
ble for normal cell growth and proliferation [1-3]. It is 
also suggested that calmodulin plays a role in Ca -'+- 
dependent cell growth regulation [4,5]. A wide variety 
of transformed cells, by contrast, show a markedly re- 
duced dependence on Ca 2. [1,6,7] and increased levels 
of the cellular calmodulin content, as compared to nor- 
mal cells [8°9]. Indeed, there is an inverse correlation 
observed between the Ca'-+-dependence and tumo- 
rigenic potency in vivo [10]. It is still unclear, however, 
how Ca-~*/calmodulin acts in the cell growth regulatory/ 
signalling cascade. We have recently observed in Swiss- 
mouse 3T3 fibroblasts that a reduction in the extracellu- 
lar calcium concentration ([Ca]o~) inhibits bombesin- 
induced DNA synthesis without inhibiting any of the 
bombesin-induced early cellular events, including initial 
transient Ca '-+ mobilization, activation of protein kinase 
C and $6 kinase, and protooncogene expression, for up 
to 4 h after bombesin addition [11]. These results sug- 
gest the existence of a Ca2+-dependent process relatively 
late in the signal transduction pathway that leads to 
DNA synthesis. 
RB protein, the product of a tumor suppressor retino- 
blastoma gene, has been implicated as a regulator of 
normal cell growth: it becomes hyperphosphorylated 
prior to the onset of DNA synthesis in growth-stimu- 
lated cells [12,13], but remains in the under- 
phosphorylated state in either terminally differentiating 
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cells [13-15] or senescent cells [13,16]. The cellular 
mechanism underlying rowth factor-induced RB pro- 
tein phosphorylation is not yet fully understood. 
In the present study, we provide evidence for the 
involvement of Ca~-+/calmodulin relatively late in the 
mitogenic signalling pathway that leads to RB phospho- 
rylation. 
2. MATERIALS AND METHODS 
Human umbilical vein endothelial cells were maintained in a sub- 
confluent state as described [12]. Cells as passages 3-8 were used in 
the present study, Before each experiment confluent cells were de- 
prived of growth factors by incubation i serum-free media containing 
0.2% bovine serum albumin for 2411. Cells were then incubated infresh 
media containing various concentrations of CaCI. [11], with or with- 
out a combination ofbasic fibroblast growth factor (bFGF) (1 ng,/ml. 
Collaborative Research Inc.), epidermal growth factor (EGF} (10 ng/ 
ml, Wakunaga Pharmaceutical Co.) and 3% fetal bovine serum that 
had been extensively dialyzed against a 0,85% NaCI solution, in the 
presence or absence of W-7 or W- 12 ( Seikagak u Kogyo). For measure- 
ment of DNA synthesis, cells were pulse-labeled with ['~H]thymidine 
(2/~Ci/ml) during the last 1 h of the indicated periods of incubations 
[11]. In parallel cultures RB protein phosphorylation was analyzed by 
7.5% SDS.PAGE with 20/~g protein in each gel slot, followed by 
Western blot using a mouse monoclonal nti-human RB peptide anti- 
body (Triton Diagnostics) and an alkaline phosphatase-conjugated 
rabbit anti-mouse IgG antibody (Zymed Laboratory). as described by 
Deeaprio et el. [12]. 
3. RESULTS AND DISCUSSION 
Stimulation of growth factor-deprived human umbil- 
ical vein endothelial cells with a combination of growth 
factors (bFGF, EGF and dialyzed serum) results in an 
increase'in DNA synthesis after a lag period (G 1 phase) 
of approximately 15 h (Fig. IA). The growth factor- 
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Fig. 1. (A) Time-course of DNA synthesis nduced by a combination 
of/growth factors, i,e, bFGF(I nffr~l), EGF(10 ng/ml) and dialyzed 
serum (3%), at 1.8 mM extracellular calcium concentration ([Ca]ou0, 
(B) Effects of ICe]o= (0.03 vs. 1.8 raM) and a ¢almodulin antagonist, 
W-7, vs. inactive analogue, W-12 (30 pM each), on DNA synthesis, 
Ceils were incubated for 24 h. GFs, llrowth factors. Results are from 
typical sets of experiments performed in triplicate (mean +_ S.E.M.). 
Z 
cao 201 I 
=,.- , , , . .  
0= 
o.e% i---i 
! "  
o 0 4 8 12 16 - 
Time of ¢at¢ium Reduction 
{laaurs a f te r  ,~aaition of 6Fo ) 
Fig. 2. A reduction in [Ca]o~, 8 h but not 16 h after addition of the 
growth factors potently inhibits DNA synthesis, [Ca]o.t was reduced 
from 1.8 to 0.03 mM at indicated time points (h) in the continued 
pre,~ence of the growth factors (fiFs), and [~H]thymidine incorpora- 
tion into DNA was compared at 24 h. - denotes that [tale., was fixed 
at 1,8 mM throughout the 24 h experimental period, Data represent 
the mean ± S.E.M. of three determinations. 
induced increase in DNA synthesis is absolutely de- 
pendent on [Ca]out (Fig. 1B); it is barely detectable at 
0.03 mM calcium, increases linearly with increasing cal- 
cium concentration for up to 0.5 raM, and reaches a 
maximal value at approximately 1 mM calcium. Cells 
are fully viable under these and the following experi- 
mental conditions, as judged by phase contrast micros- 
copy and Trypan blue exclusion. The combined effect 
of growth factors on DNA synthesis at 1.8 mM calcium 
is totally abolished by the potent calmodulin antagonist, 
W-7 (30/xM), but not by the inactive analogue, W-12 
(30 #M), which has approximately 10-times lower affin- 
ity for calmodulin than W-7 [9] (Fig. 1B), indicating that 
the effect of W-7 is relatively specific and is likely based 
on antagonism against calmodulin. 
To explore the site of action of Ca ~'* along the mite- 
genie signal transduction pathway, calcium was reduced 
at various time points after addition of the growth fac- 
tors, and the rate or DNA synthesis was compared at 
24 h. As shown in Fig. 2, a reduction in [Ca]out as late 
as 8 h after growth factor stimulation inhibits DNA 
synthesis to a comparable extent as in ceils for which 
[Ca]out was 0.03 mM from the beginning. However, a 
reduction in [Ca]oat at much later time points fails to 
inhibit DNA synthesis measured at 24 h. These results 
are consistent with our previous observation [11] and 
suggest the existence of a Ca:*-dependent process rela. 
tively late in the GI phase of the cell cycle, i.e. after 
growth factor-induced arly cellular events, such as re- 
ceptor/tyrosine kinase activation, an initial transient 
Ca :+ mobilization and immediate-early protooneogene 
expression. 
We neat examined the effects of [Ca]out and the eal- 
modulin antagonist on growth factor-induced RB pro. 
rein phosphorylation (Fig. 3). As reported for various 
human cell types, including endothelial cells [12], hyper- 
phosphorylated forms of RB protein (H in Fig. 3A) 
show delayed mobility on SDS-PAGE and are clearly 
identified on Western blot as at least three distinct 
bands above the underphosphorylated form (U in Fig. 
3A). A time-dependent increase in RB protein phospho- 
rylation in growth factor-stimulated cells at 1.8 mM of 
calcium is shown in Fig. 3A. The amount of the hyper- 
phosphorylated forms of RB protein starts to increase 
between 12 and 16 h after addition of the growth fac- 
tors, and continues to increase for up to 24 h. By con- 
trast, there is little change in the amount of the under- 
phosphorylated form of RB protein throughout the 
observation period. As shown in Fig. 3B, at 0.03 mM 
of [Ca]o.t, the growth factors fail to induce RB phospho- 
rylation even after 24 h, just like DNA synthesis (Fig. 
1B). A reduction in [Ca]ou~ from 1.8 to 0.03 mM 6 h, but 
not 16 h after growth stimulation, nearly completely 
inhibits RB phosphorylation at 24 h (Fig. 3C), just as 
in the case with DNA synthesis (Fig. 2). Similarly, an 
addition of W-7, but not W-12, as late as 8 h after 
growth stimulation effectively inhibits RB phosphoryla- 
tion at 24 h, however, it is without effect if applied at 
12 h or later (Fig. 3D). These results strongly suggest 
that at least one site of action of CaO-+/calmodulin is 
located in the late G1 phase, at a step proximal to RB 
phosphorylation reaction itself since, once RB becomes 
phosphorylatcd 12-1(5 h after addition of the growth 
factors (Fig. 3A), it is not dephosphorylated hereafter 
by either a reduction in ICe]out or  the calmodulin antag- 
onist (Fig. 3C and D). Indeed, it has been reported that 
a putative RB kinase, p34 ~''~-, which phosphorylates RB
protein with an identical tryptic phosphopeptide map as 
that observed in proliferating cells [17,18], requires nei- 
ther Ca -~* nor calmodulin for in vitro kinase activity 
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Fig, 3. Analysis of RB protein phosphorylation byWestern blotting. 
(A) Time-course of RB phosphorylation after addition of the growth 
factors (GFs), Hyperphosphorylated (H) and underphosphorylated 
(U) forms of RB protein are indicated to the right, (B) The effect of 
[Ca]o~, on RB phosphorylation, Cells were incubated at either 0.03 or 
1.8 mM of [Ca]o., in the presence or absence of the growth factors for 
24 h. (C) A reduction in [Ca]o°t 6h but not 16 h after addition, of" i, li¢ 
growth factors potently inhibits RB phosphorylation at 24 h. (D) 
Effects of W-7 and W.I 2 on RB phosphorylation. Tile antagonists (30 
/aM) were introduced to the cultures at indicated time points (h) after 
addition of the growth factors, and RB phospho~latlon was analyzed 
at 24 h, 
[17-19]. It would be o f  particular interest to test the 
possibility whether either the expression or phosphory l -  
at ion state o f  p34 ~2 or related kinases (and/or o f  their 
regulatory protein(s) such as cyclin) is regulated in a 
manner  dependent on Ca-'* and calmodulin.  
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